328
Views
7
CrossRef citations to date
0
Altmetric
Psoriasis

Development and psychometric evaluation of the self-assessment of psoriasis symptoms (SAPS) – clinical trial and the SAPS – real world patient-reported outcomes

, , , , &
Pages 505-514 | Received 10 Jan 2017, Accepted 27 Jan 2017, Published online: 02 Mar 2017

References

  • American Academy of Dermatology. Psoriasis Shaumburg, IL: American Academy of Dermatology; 2015. Available from: https://www.aad.org/public/diseases/scaly-skin/psoriasis. Accessed October 11, 2015.
  • Rachakonda TD, Schupp CW, Armstrong AW. Psoriasis prevalence among adults in the United States. J Am Acad Dermatol. 2014;70:512–16.
  • National Psoriasis Foundation. About Psoriasis Portland, OR: National Psoriasis Foundation; 2015. Available from: https://www.psoriasis.org/about-psoriasis. Accessed June 12, 2015.
  • Fredriksson T, Pettersson U. Severe psoriasis-oral therapy with a new retinoid. Dermatologica. 1978;157:238–44.
  • Langley RG, Ellis CN. Evaluating psoriasis with Psoriasis Area and Severity Index, Psoriasis Global Assessment, and Lattice System Physician's Global Assessment. J Am Acad Dermatol. 2004;51:563–9.
  • Takeshita J, Duffin KC, Shin DB, et al. Patient-reported outcomes for psoriasis patients with clear versus almost clear skin in the clinical setting. J Am Acad Dermatol. 2014;71:633–41.
  • Kitchen H, Cordingley L, Young H, et al. Patient-reported outcome measures in psoriasis: the good, the bad and the missing!. Br J Dermatol. 2015;172:1210–21.
  • Strober BE, Nyirady J, Mallya UG, et al. Item-level psychometric properties for a new patient-reported psoriasis symptom diary. Value Health. 2013;16:1014–22.
  • Naegeli AN, Flood E, Tucker J, et al. The Worst Itch Numeric Rating Scale for patients with moderate to severe plaque psoriasis or psoriatic arthritis. Int J Dermatol. 2015;54:715–22.
  • Revicki DA, Jin Y, Wilson HD, et al. Reliability and validity of the psoriasis symptom inventory in patients with moderate-to-severe psoriasis. J Dermatolog Treat. 2014;25:8–14.
  • Gilet H, Roborel de Climens A, Arnould B, et al. Development and psychometric validation of the REFlective evaLuation of psoriasis Efficacy of Treatment and Severity (REFLETS) questionnaire: a common measure of plaque-type psoriasis severity and treatment efficacy for patients and clinicians. J Eur Acad Dermatol Venereol. 2015;29:498–506.
  • US Department of Health and Human Services, Food and Drug Administration, Center for Drug Evaluation and Research, Center for Biologics Evaluation and Research, Center for Devices and Radiological Health. Guidance for Industry: Patient-Reported Outcome Measures: Use in Medical Product Development to Support Labeling Claims, 2009.
  • Hammersley M, Atkinson P, Ethnography: Principles in Practice, 3rd ed. New York, NY: Routledge, 2007.
  • Weitzman EA, Miles MB, Computer Programs for Qualitative Data Analysis. London: Sage Publications, 1995.
  • Hsieh HF, Shannon SE. Three approaches to qualitative content analysis. Qual Health Res. 2005;15:1277–88.
  • Patrick DL, Burke LB, Gwaltney CJ, et al. Content validity-establishing and reporting the evidence in newly developed patient-reported outcomes (PRO) instruments for medical product evaluation: ISPOR PRO good research practices task force report: part 1-eliciting concepts for a new PRO instrument. Value Health. 2011;14:967–77.
  • Rothman M, Burke L, Erickson P, et al. Use of existing patient-reported outcome (PRO) instruments and their modification: the ISPOR good research practices for evaluating and documenting content validity for the use of existing instruments and their modification PRO task force report. Value Health. 2009;12:1075–83.
  • Glaser BG, Strauss A, The Discovery of Grounded Theory: Strategies for Qualitative Research. Chicago: Aldine Transaction, 1967.
  • Shields AL, Shiffman S, Stone A, Recall bias: understanding and reducing bias in PRO data collection. In: Tiplady B, Byrom B, eds. ePRO: electronic solutions for patient-reported data. Burlington, VT: Ashgate Publishing Company, 2010. p 5–21.
  • Ericsson KA, Simon HA, Protocol Analysis: Verbal reports as data. Cambridge, MA: MIT Press, 1993.
  • Willis GB, Cognitive Interviewing: A Tool for Improving Questionnaire Design. Sage Publications: Thousand Oaks, 2005.
  • Finlay AY, Khan GK. Dermatology Life Quality Index (DLQI)-a simple practical measure for routine clinical use. Clin Exp Dermatol. 1994;19:210–16.
  • Dermatology Quality of Life Index (DLQI) 2016. Available from: http://sites.cardiff.ac.uk/dermatology/quality-of-life/dermatology-quality-of-life-index-dlqi/. Accessed March 29, 2016.
  • Cronbach LJ. Coefficient alpha and the internal structure of tests. Psychometrika 1951;16:297–334.
  • Nunnally JC, The assessment of reliability. In: Bernstein I, ed. Psychometric Theory. New York: McGraw Hill, 1994. p 248–92.
  • Bland JM, Altman DG. Cronbach's alpha. BMJ. 1997;314:572.
  • Cohen J, Statistical Power Analysis for the Behavioral Sciences. New York: Academic Press, 1977.
  • Cohen J. A power primer. Psychol Bull. 1992;112:155–9.
  • Nunnally J, Bernstein I, Psychometric Theory. 3rd ed. New York: McGraw-Hill, 1994.
  • Snyder CF, Aaronson NK. Use of patient-reported outcomes in clinical practice. The Lancet. 2009;374:369–70.
  • Nelson EC, Hvitfeldt H, Reid R, et al. Using Patient-Reported Information to Improve Health Outcomes and Health Care Value: Case Studies from Dartmouth, Karolinska and Group Health. Lebanon, NH: The Dartmouth Institute for Health Policy and Clinical Practice, 2012.
  • Patrick DL, Burke LB, Gwaltney CJ, et al. Content validity-establishing and reporting the evidence in newly developed patient-reported outcomes (PRO) instruments for medical product evaluation: ISPOR PRO good research practices task force report: part 2-assessing respondent understanding. Value Health. 2011;14:978–88.
  • Deshpande PR, Rajan S, Sudeepthi BL, Abdul Nazir CP. Patient-reported outcomes: a new era in clinical research. Perspect Clin Res. 2011;2:137–44.
  • Wild D, Grove A, Martin M, et al. Principles of good practice for the translation and cultural adaptation process for patient-reported outcomes (PRO) measures: report of the ISPOR task force for translation and cultural adaptation. Value Health. 2005;8:94–104.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.